Riskpilot← Back to searchSign inGet full accessTrianon Medicinen AB
ABActiveOrg 5593692436Rental and operating of own or leased real estate · NACE 6820Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
+68% vs 2023
Equity ratio
0.1%
Financial strength
Net profit 2024
SEK -153K
-220% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -103K | +68% |
| Net profit | SEK -153K | -220% |
| Total assets | SEK 14,8M | +6% |
| Equity | SEK 13K | -91% |
| Employees | 0 | — |
Legal name
Trianon Medicinen AB
Org number
5593692436
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
8 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget ska äga och förvalta fast egendom och därmed förenlig verksamhet.
Address
Email
ekonomi@trianon.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | −0 | — | — |
| EBITDA | −104 | −0 | −320 | −103 |
| Depreciation & amort. | −0 | −0 | −55 | −113 |
| EBIT | −104 | −0 | −375 | −216 |
| Net financials | — | 0 | −105 | −402 |
| Profit before tax | −4 | 4 | 161 | −193 |
| Tax | −0 | −0 | −33 | 40 |
| Net profit | −4 | 4 | 128 | −153 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 99 | 99 | 13 892 | 14 763 |
| Equity | 21 | 21 | 149 | 13 |
| Long-term debt | 0 | 0 | 4 119 | 4 119 |
| Short-term debt | 78 | 78 | 9 589 | 10 496 |
| Total debt | 78 | 78 | 13 708 | 14 615 |
EBITDA margin
-10300000.0%
This company
15.8%
Market median
-65189973% vs market
20222024
Equity ratio
0.1%
This company
38.2%
Market median
-100% vs market
20222024
Return on equity
-1176.9%
This company
18.4%
Market median
-6496% vs market
20222024
Net profit margin
-15300000.0%
This company
8.1%
Market median
-188888989% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
1134.62×
This company
0.62×
Market median
-182903% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-08 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
AO Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fastighets Aktiebolaget Trianon
Trianon Medicinen AB Board members of Trianon Medicinen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Olof Persson | Chief Auditor | 0 companies |
| Maria Elisabet Lidborn | Chief Auditor | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Jonas Alexander Karlsryd | Board of Directors | 0 companies |
| Anna Beatrice Heide | Board of Directors | 0 companies |
| Carin Mari-Louise Hedbys | Chairman | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |
| Lars Olof Andersson | Chairman | 0 companies |